Sun-Young Jang - Search Results

Year	Number of Results
2004	1
2010	3
2011	3
2012	4
2013	8
2014	7
2015	10
2016	11
2017	8
2018	8
2019	8
2021	11
2022	7
2023	5
2024	1

1

Jang SY. Jang SY. Korean J Neurotrauma. 2018 Apr;14(1):1-5. doi: 10.13004/kjnt.2018.14.1.1. Epub 2018 Apr 30. Korean J Neurotrauma. 2018. PMID: 29774191 Free PMC article. Review.

2

Acupuncture attenuates comorbid anxiety- and depressive-like behaviors of atopic dermatitis through modulating neuroadaptation in the brain reward circuit in mice.

Yeom M, Ahn S, Jang SY, Jang JH, Lee Y, Hahm DH, Park HJ. Yeom M, et al. Among authors: jang sy. Biol Res. 2022 Sep 10;55(1):28. doi: 10.1186/s40659-022-00396-0. Biol Res. 2022. PMID: 36088447 Free PMC article.

3

Update on the surgical management of Graves' orbitopathy.

Baeg J, Choi HS, Kim C, Kim H, Jang SY. Baeg J, et al. Among authors: jang sy. Front Endocrinol (Lausanne). 2023 Feb 6;13:1080204. doi: 10.3389/fendo.2022.1080204. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36824601 Free PMC article. Review.

4

The Role of Adipsin, Complement Factor D, in the Pathogenesis of Graves' Orbitopathy.

Byeon HJ, Chae MK, Ko J, Lee EJ, Kikkawa DO, Jang SY, Yoon JS. Byeon HJ, et al. Among authors: jang sy. Invest Ophthalmol Vis Sci. 2023 Aug 1;64(11):13. doi: 10.1167/iovs.64.11.13. Invest Ophthalmol Vis Sci. 2023. PMID: 37555734 Free PMC article.

5

Intractable Intradialytic Hypotension with Ischemic Retinopathy.

Shin IS, Choi SJ, Kim BY, Kim JK, Hwang SD, Jang SY. Shin IS, et al. Among authors: jang sy. Blood Purif. 2017;43(1-3):89-90. doi: 10.1159/000449420. Epub 2016 Dec 3. Blood Purif. 2017. PMID: 27915344 Free article. No abstract available.

6

Therapeutic Potential of Targeting Periostin in the Treatment of Graves' Orbitopathy.

Jang SY, Kim J, Park JT, Liu CY, Korn BS, Kikkawa DO, Lee EJ, Yoon JS. Jang SY, et al. Front Endocrinol (Lausanne). 2022 May 30;13:900791. doi: 10.3389/fendo.2022.900791. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35707463 Free PMC article.

7

Wnt signalling inhibits adipogenesis in orbital fibroblasts from patients with Graves' orbitopathy.

Jung SJ, Choi YJ, Park TK, Woo SE, Kim BY, Yoon JS, Jang SY. Jung SJ, et al. Among authors: jang sy. Br J Ophthalmol. 2022 Jul;106(7):1019-1027. doi: 10.1136/bjophthalmol-2020-316898. Epub 2021 Jun 30. Br J Ophthalmol. 2022. PMID: 34193409

8

Meibomian gland dysfunction in Graves' orbitopathy.

Kim YS, Kwak AY, Lee SY, Yoon JS, Jang SY. Kim YS, et al. Among authors: jang sy. Can J Ophthalmol. 2015 Aug;50(4):278-82. doi: 10.1016/j.jcjo.2015.05.012. Can J Ophthalmol. 2015. PMID: 26257221

9

Phospholipase C-γ as a Potential Therapeutic Target for Graves' Orbitopathy.

Roh TH, Chae MK, Ko JS, Kikkawa DO, Jang SY, Yoon JS. Roh TH, et al. Among authors: jang sy. Endocrinol Metab (Seoul). 2023 Dec;38(6):739-749. doi: 10.3803/EnM.2023.1780. Epub 2023 Nov 21. Endocrinol Metab (Seoul). 2023. PMID: 37989267 Free PMC article.

10

Synthesis and anti-tumor activity of imidazopyrazines as TAK1 inhibitors.

Kang SJ, Lee JW, Chung SH, Jang SY, Choi J, Suh KH, Kim YH, Ham YJ, Min KH. Kang SJ, et al. Among authors: jang sy. Eur J Med Chem. 2019 Feb 1;163:660-670. doi: 10.1016/j.ejmech.2018.12.025. Epub 2018 Dec 13. Eur J Med Chem. 2019. PMID: 30576901

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

82 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year